Bone Density Testing in Perimenopause and Menopause: DXA & REMS Ultrasound
Why Early Baseline Testing Matters for Women 40+
Bone loss doesn’t start at osteoporosis — it starts quietly, often years before menopause. By the time a woman is diagnosed with osteopenia or osteoporosis, significant bone changes have already occurred. That’s why early baseline bone density testing in perimenopause is one of the most underutilized tools in women’s preventive health.
Understanding your baseline allows you to:
Track bone changes over time
Intervene earlier with lifestyle, nutrition, or hormonal support
Reduce fracture risk later in life
Two technologies dominate the conversation today: DXA scans and REMS ultrasound bone density testing. While they share a goal, they also differ in several ways.
What Is Bone Density Testing?
Bone density testing measures the strength and mineral content of bones, most commonly at the spine and hip — areas most vulnerable to osteoporotic fractures. Results help determine fracture risk and guide prevention or treatment strategies.
For women entering perimenopause or menopause, testing offers insight into how hormonal changes — especially declining estrogen — are impacting skeletal health.
DXA Scan: The Traditional Bone Density Test
How DXA Works
DXA (Dual-energy X-ray Absorptiometry) uses low-dose X-rays to measure bone mineral density (BMD). It has long been considered the clinical “gold standard.”
What DXA Measures
T-score: Compares your bone density to that of a healthy 30-year-old woman
Z-score: Compares your bone density to women your age
These scores categorize bone health as:
Normal
Osteopenia (low bone density)
Osteoporosis (advanced bone loss)
Pros of DXA Testing
Widely accepted and recognized
Often covered by insurance (especially after age 65 or with risk factors)
Standardized reporting used in treatment guidelines
Limitations for Midlife Women
Uses ionizing radiation (but very low dose)
Typically recommended after age 65 — missing early bone loss years
Limited insight into bone quality (not just density)
Fixed machines limit accessibility and convenience
Many women do not qualify for DXA until bone loss is already present — which is why baseline alternatives matter.
REMS Ultrasound Bone Density Testing: A Newer Option
What Is REMS?
REMS (Radiofrequency Echographic Multi Spectrometry) is an advanced ultrasound-based bone density technology that assesses the spine and hip without radiation.
What Makes REMS Different
REMS analyzes raw ultrasound signals to evaluate both:
Bone density (T-scores and Z-scores)
Bone quality, via a Fragility Score, an exclusive REMS metric, ranging from 0–100, which evaluates bone microarchitecture quality to predict fracture risk, regardless of bone mineral density.
Benefits of REMS for Perimenopausal & Postmenopausal Women
No radiation — safe for earlier and more frequent testing
Accessible for early baseline testing
Portable and available in more wellness-focused clinics
Immediate results and interpretation
Better suited for tracking year-to-year bone changes
Limitations to Know
Typically not covered by insurance (out-of-pocket expense)
Not yet as universally adopted as DXA
Some clinicians may be less familiar with interpretation
DXA vs. REMS: Key Differences at a Glance
| Feature | DXA Scan | REMS Ultrasound |
|---|---|---|
| Technology | X-ray | Ultrasound |
| Radiation | Yes (very low dose) | None |
| Age requirement | Standard Care is 65+ or high risk | None |
| Bone Quality Assessment | No | Yes (Fragility Score) |
| Accessibility | Hospital / Imaging center | Clinics, mobile, wellness settings |
| Reporting Time | Days–weeks | Same-day |
| Insurance Coverage | Often covered | Self-pay |
| Monitoring Frequency | Limited (recommended every 2 years) | Can be repeated more often |
Why Baseline Bone Density Testing Before 65 Is Critical
Women can lose up to 20% of their bone mass in the first 5–7 years after menopause. Waiting until age 65 to test means missing the most dynamic window for prevention.
Early baseline testing allows you to:
Identify accelerated bone loss early
Correlate bone changes with hormonal shifts
Evaluate the impact of HRT, nutrition, exercise, and/or supplements
Make informed decisions before fractures occur
REMS ultrasound fills an important gap for women who want proactive data, not delayed diagnoses.
Cost & Accessibility: What to Expect
DXA Scan
Cost: ~$100–$500 depending on location and insurance
Coverage: Often covered with referral or age/risk criteria
Access: Hospitals and imaging centers
REMS Testing
Cost: ~$250–$425 out of pocket (varies by clinic)
Coverage: Insurance coverage is limited but evolving
Access: Wellness clinics, women’s health practices, mobile services
For many women, REMS is viewed as an investment in early prevention, similar to advanced lab testing.
Which Bone Density Test Is Right for You?
You may prefer DXA if:
Insurance coverage is essential
You already meet age or risk-based criteria
Your provider requires DXA for treatment decisions
You may prefer REMS if:
You’re in perimenopause or early menopause
You want a baseline before bone loss accelerates
You prefer a radiation-free option
You want insight into bone quality, not just density
Many women use REMS for early monitoring and DXA later for clinical confirmation.
Takeaway: Bone Health Is a Midlife Priority, Not a Late-Life One
Bone density testing isn’t just about diagnosing osteoporosis — it’s about understanding your trajectory. For perimenopausal and postmenopausal women, early baseline testing can be the difference between prevention and reaction.
Whether you choose DXA, REMS, or both, the most important step is starting sooner rather than later.